SW
TNGX icon

Simplicity Wealth’s Tango Therapeutics TNGX Stock Holding History

Simplicity Wealth’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-26,961
Closed -$226K – 774
2025
Q3 		$226K Hold
26,961
– – 0.01% 644
2025
Q2 		$138K Hold
26,961
– – 0.01% 574
2025
Q1 		$36.9K Hold
26,961
– – ﹤0.01% 550
2024
Q4 		$83.3K Hold
26,961
– – 0.02% 321
2024
Q3 		$208K Sell
26,961
-16,080
-37% -$153K 0.02% 474
2024
Q2 		$369K Buy
43,041
+16,080
+60% +$124K 0.01% 872
2024
Q1 		$214K Buy
+26,961
New +$289K 0.01% 1039

Other funds holding TNGX

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Simplicity Wealth's TNGX Position: Q4 2025 in Review

Simplicity Wealth sold out of Tango Therapeutics (TNGX) in Q4 2025, closing a stake of 26,961 shares — an estimated $226K sold.

Simplicity Wealth first reported a position in TNGX in Q1 2024 and held it in 7 quarters. The position peaked at $369K in Q2 2024. 170 funds tracked by Wall St. Rank hold TNGX as of Q4 2025.

  • Simplicity Wealth reported no remaining Tango Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Simplicity Wealth sold 26,961 Tango Therapeutics shares in Q4 2025, an estimated $226K.
  • Simplicity Wealth first reported a position in Tango Therapeutics in Q1 2024 and held it in 7 quarters.
  • Simplicity Wealth's Tango Therapeutics position peaked at $369K in Q2 2024.
  • 170 funds tracked by Wall St. Rank held Tango Therapeutics as of Q4 2025.

Based on Simplicity Wealth's 13F filing for Q4 2025, filed 30 Jan 2026.